Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Columbia Labs

This article was originally published in The Tan Sheet

Executive Summary

Replens, Diasorb, Vaporizer in a Bottle and Legatrin brands to be sold to an unnamed party as focus shifts to prescription products, the firm acknowledges March 23. The divestiture plan, announced last autumn, will be completed in about 30 days (1"The Tan Sheet" Oct. 18, 1999, p. 10). The company says March 20 it has reacquired U.S. rights to Advantage-S nonoxynol-9 spermicidal gel, its sole remaining OTC, by settling a legal dispute with former licensee Lake Consumer Products for $1.2 mil. in cash and stock. Study results on Advantage-S and HIV/STD prevention are expected in about 90 days in a U.N. Global Program on AIDS report. Advantage-S sales improved to $400,000 in 1999 from $340,000 in 1998, during part of which litigation made the product unavailable
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel